Investors



EXCHANGE: NASDAQ
Change
Change (%)
Volume
Data as of
Minimum 15 minute delay
Refresh quote

LEARN MORE

INVESTOR KIT

Recent Press Releases

  • AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Polypropylene Suture-Anchor Assembly for use specifically with the OverStitch™ Endoscopic Suturing Systems. This proprietary suture-anchor implant is used as part of Apollo’s OverStitch™ and OverStitch Sx™more...
  • AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it has closed its previously announced private placement of $20 million of unsecured convertible debentures to accredited and institutional investors. Interest on the debentures is payable semi-annually in common stock, or in kind in certain situations, at a rate per annum of 6.0%. At any timemore...
Business Wire InvestorHQ℠